Abstract
Background Endovenous angioplasty with stenting is an accepted treatment for patient with venous obstruction. Dedicated venous stents have been developed to improve the efficacy and safety of the venoplasty procedure. We report the procedural as well as clinical outcomes of these new generation stents in the treatment of acute and chronic venous obstruction. Method This is a single centre retrospective cohort study of patients who received venous stenting for either acute or chronic venous obstruction. Baseline demographics, procedural details, clinical outcomes including 30 day all-cause mortality, 90 day primary patency rate, and change in Villalta score were reported. Result 41 patients with venous obstruction were included in this study. The mean Villalta score before the procedure was 13.8 (±3.8). Extrinsic compression of the affected vein was found in 95.1% of cases. Procedural success was achieved in 97.6% of cases, with 2±1 stents of mean diameter of 15.3mm +/- 1.9mm and total stented length of 179.3mm±85.3mm used per case. There were no procedural complications. 90 days primary patency rate was 90.2%. The Villalta score decreased by 9.2±0.7 to 4.6±2.4 at 90 days. Conclusion Endovenous angioplasty with new generation of dedicated venous stents is a safe and effective treatment option for patients with acute and chronic venous obstruction.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.